Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion type Assertion NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_head.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion wasGeneratedBy ECO_0000203 NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion wasDerivedFrom befree-20150227 NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion SIO_000772 21039418 NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion evidence source_evidence_literature NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.
- NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_assertion description "[Clinical results of osanetant and talnetant (selective-NK₃ antagonists) indicate that blocking the NK₃ receptor could be beneficial for the treatment of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524364.RADzYtXZz_zyPQll81G_du1SP_rFYep1n5RWPvS3THGlA130_provenance.